A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients

Kornvipa Settakorn, Sasinee Hantrakool, Touchwin Petiwathayakorn, Nuntouchaporn Hutachok, Adisak Tantiworawit, Pimlak Charoenkwan, Nopphadol Chalortham, Anchan Chompupoung, Narisara Paradee, Pimpisid Koonyosying, Somdet Srichairatanakool

Open source

DOI: 10.3389/fmolb.2023.1248742
Published: 2024-01-24
Container: Frontiers in Molecular Biosciences
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmolb.2023.1248742,
  title = {A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients},
  author = {Kornvipa Settakorn and Sasinee Hantrakool and Touchwin Petiwathayakorn and Nuntouchaporn Hutachok and Adisak Tantiworawit and Pimlak Charoenkwan and Nopphadol Chalortham and Anchan Chompupoung and Narisara Paradee and Pimpisid Koonyosying and Somdet Srichairatanakool},
  year = {2024},
  journal = {Frontiers in Molecular Biosciences},
  doi = {10.3389/fmolb.2023.1248742},
  url = {https://doi.org/10.3389/fmolb.2023.1248742}
}

RIS

TY  - JOUR
TI  - A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients
AU  - Kornvipa Settakorn
AU  - Sasinee Hantrakool
AU  - Touchwin Petiwathayakorn
AU  - Nuntouchaporn Hutachok
AU  - Adisak Tantiworawit
AU  - Pimlak Charoenkwan
AU  - Nopphadol Chalortham
AU  - Anchan Chompupoung
AU  - Narisara Paradee
AU  - Pimpisid Koonyosying
AU  - Somdet Srichairatanakool
PY  - 2024
JO  - Frontiers in Molecular Biosciences
DO  - 10.3389/fmolb.2023.1248742
UR  - https://doi.org/10.3389/fmolb.2023.1248742
ER  -

APA

Settakorn, K., Hantrakool, S., Petiwathayakorn, T., Hutachok, N., Tantiworawit, A., Charoenkwan, P., Chalortham, N., Chompupoung, A., Paradee, N., Koonyosying, P., & Srichairatanakool, S. (2024). A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2023.1248742

Source records

crossref · retrieved 2026-09-26T21:01:35.616Z